Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus
Proceedings of the National Academy of Sciences · 30.09.2025 · 122 (39)
DOI: 10.1073/pnas.2507962122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 25.09.2025. Verfasst von Kyle J Card und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106. Hauptthemen laut MEDLINE: Vancomycin, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, HHS | NIH (NIH).
Abstract (Originalsprache)
Staphylococcus aureus bacteremia is typically treated empirically with vancomycin, with therapy later tailored based on susceptibility results. However, these tests occur before vancomycin exposure and do not account for adaptation during empiric treatment that can alter S. aureus ’ susceptibility to first-line drugs. To investigate these collateral drug responses, we experimentally evolved 18 methicillin-susceptible S. aureus (MSSA) populations under increasing vancomycin concentrations until they achieved intermediate resistance. Genomic sequencing revealed two distinct adaptive pathways characterized by mutations in the WalKR regulon, affecting cell wall metabolism, or rpsU , impacting translational stress responses. These pathways correlated with divergent collateral sensitivity profiles to first-line antibiotics. By developing a Collateral Response Score (CRS), we quantified the probability and magnitude of these responses, demonstrating that evolutionary dynamics critically influence resistance outcomes. Our findings suggest a probabilistic approach to antimicrobial therapy, advocating for rapid genomic diagnostics alongside susceptibility testing to better anticipate and respond to evolutionary changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106.
- Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44106.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Physics, Case Western Reserve University, Cleveland, OH 44106.
- Department of Biology, Case Western Reserve University, Cleveland, OH 44106.
- Medical Service, Louis Stokes Cleveland Department of Veteran Affairs Medical Center, Cleveland, OH 44106.
ORCID-Profile: Kyle J Card, Justin Creary, Robert A Bonomo, Zachary D C Burke, Jacob G Scott
Förderung
- NCI NIH HHS
- HHS | NIH (NIH)
Zitieren
APA
Card, K. J., Crozier, D., Durmaz, A., Gray, J., Creary, J., Stocks, A., Maltas, J., Bonomo, R. A., Burke, Z. D. C., & Scott, J. G. (2025). Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus. Proceedings of the National Academy of Sciences, 122(39). https://doi.org/10.1073/pnas.2507962122
Vancouver
Card KJ, Crozier D, Durmaz A, Gray J, Creary J, Stocks A, et al. Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus. Proceedings of the National Academy of Sciences. 2025;122(39). doi:10.1073/pnas.2507962122
BibTeX
@article{Card2025,
author = {Card, Kyle J and Crozier, Dena and Durmaz, Arda and Gray, Jason and Creary, Justin and Stocks, Amira and Maltas, Jeff and Bonomo, Robert A and Burke, Zachary D C and Scott, Jacob G},
title = {Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {39},
doi = {10.1073/pnas.2507962122}
}
EUVIMED